Abstract: As an anti-allergic treatment for warm-blooded animals, therapeutic amounts of a compound having the formula I (including acid salts thereof) or II are administered: ##STR1## where; R is OR.sup.4 or NHR.sup.5 in which R.sup.4 is hydrogen or lower alkyl, R.sup.5 is selected from phenyl and phenyl monosubstituted with halogen, lower alkyl, lower alkoxy, R.sup.1 and R.sup.2 are independently hydrogen or lower alkyl, andR.sup.3 is selected from lower alkyl, arylcyclopropyl, naphthyl, phenyl, and phenyl monosubstituted with lower alkyl, lower alkoxy, trifluoromethyl, halogen, nitro, carboxyl, or ethyl carboxylate; ##STR2## R.sup.6 is lower alkyl, R.sup.7 is selected from phenyl and phenyl monosubstituted with lower alkyl, lower alkoxy, halogen or acetyl, and M is an alkali or alkaline earth metal.

Abstract: Alkali metal 2,5-dihydro-3-ethoxycarbonyl-2-[(substituted phenyl)amino]-4-furanyloxides are useful as anti-allergy agents.

Abstract: 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives are described.

Abstract: Substituted spiro[oxazolidine-5,2'-adamantane] compounds are described.

Abstract: 5-Substituted and/or N-Substituted 4-azatricyclo [4.3.1.1.sup.3,8 ]undecane and 4-azatricyclo[4.3.1.1.sup.3,8 ]undecan-5-one compounds are prepared.

Abstract: Treatment of warm-blooded animals infected with the herpes II virus by concurrently orally administering an antiviral agent effective against said virus and suitable for oral administration while topically applying the same or a different such agent to lesions caused by the infection. Effective antivirals include .alpha.,.alpha.-dimethyl-beta-adamantylethylamine and N,N-dialkyl,.alpha.,.alpha.-dimethyl-beta-adamantylethylamine.

Abstract: Warm-blooded animals are treated by administering to the animal a dosage, effective to alleviate the symptoms of measles, of a compound of the formula I or its acid salt: ##STR1## wherein R.sub.1 and R.sub.2 are selected from the class consisting of hydrogen and --CH.sub.3 and at least on pharmaceutically acceptable carrier, wherein the compound is 0.01 to 95% by weight of the composition.

Abstract: Warm-blooded animals are treated by administering to the animal a dosage, effective to prevent or to alleviate the symptoms of herpes virus, type II, of a compound of the formula I or its acid salt: ##STR1## wherein R.sub.1 and R.sub.2 are selected from the class consisting of H and --CH.sub.3 ; and at least one pharmaceutically acceptable carrier, wherein the compound is 0.01 to 95% by weight of the composition.